AstraZeneca and Inserm collaborate to investigate new therapeutic approaches to diabetes and CKD
17 June 2015 | By Victoria White
AstraZeneca is to collaborate with Inserm to investigate new therapeutic approaches to type 2 diabetes and Chronic Kidney Disease (CKD)...